Preclinical Trials: A Nuanced Study Process to Get Into the Clinic Faster

Medelis: An Introduction to our Oncology CRO Services in the U.S., Europe and Asia

Context Of Vulnerability in Oncology Drug Development

The Lost Art Of Phase I Oncology Trials

Dr. Dan Von Hoff discusses the complete phase Ib, a clinical trial approach that helps oncology biotech and pharma sponsors streamline Phase I and get to Phase II faster

Adaptive Trial Design in Phase I-II

Patient Safety in Clinical Trials

Medelis Oncology CRO Services

Context of Vulnerability: A New Paradigm in Oncology Drug Development

The Lost Art of Phase I Oncology Clinical Trials